m.broberg
TL2 · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 27 August 2025 · last posted 4d
88 posts, newest first. Showing up to 150.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #94 · Wellbeing › Sleep · 24 Jul 2026 · 1 like Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #26 · Outcomes › Progress reports · 20 Jul 2026 · 15 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. The documentation on Waist circumference technique is better than this thread and I…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #40 · Analytics › Method validation · 7 Jul 2026 · 6 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #93 · Compounds › Semaglutide · 6 Jul 2026 · 25 likes Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #39 · Practice › Administration · 5 Jul 2026 · 19 likes Post #36 is the version of this I will quote in future. One addition. Cold solution and stinging: warming the vial in your hands for a minute before injection reduces…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #16 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 0 likes Narrowing post #15, because the general version has more than one answer. Checked the Theoretical plates claim against the primary source this morning. It survives,…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #51 · Compounds › Secretagogues & GH axis · 27 Jun 2026 · 31 likes I disagree with the framing of secretagogues and glucose tolerance above, and I think it is a substantive disagreement rather than a terminological one. Setting out…
-
Submitting a sample: the process end to end Replied, post #28 · Sourcing › Independent verification · 20 Jun 2026 · 7 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #33 · Access › Pricing · 11 Jun 2026 · 9 likes Post #29 describes the usual case. This is about the unusual one. I would call the community position on manufacturer assistance programmes likely rather than…
-
When a network meta-analysis is defensible and when it is not Replied, post #2 · Evidence › Meta-analyses · 4 Jun 2026 · 2 likes Narrowing the opening post, because the general version has more than one answer. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion…
-
Bioimpedance and hydration: why the number moves Replied, post #53 · Outcomes › Body composition · 31 May 2026 · 1 like Something worth flagging about bioimpedance and hydration: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #50 · Evidence › Journal club · 7 May 2026 · 0 likes Picking up post #47: that is the part I would want checked first. The version of indirect comparison that I was taught turned out to be a teaching simplification.…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #20 · Analytics › Home & field testing · 1 May 2026 · 0 likes What I would want before treating Reflectance and photometric devices as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Why this subcategory is stricter about sourcing than most Replied, post #10 · Compounds › Secretagogues & GH axis · 21 Mar 2026 · 22 likes Post #8 describes the usual case. This is about the unusual one. A mass result for a short peptide is more discriminating than for a long one, because a single residue…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #73 · Lounge › Introductions · 15 Mar 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Which fields on a certificate actually matter, ranked Replied, post #5 · Analytics › COA interpretation · 11 Mar 2026 · 1 like Post #4 is right about the mechanism and I think understates the practical bit. An itemised related-substances table with retention times says considerably more about…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #23 · Compounds › Repair & healing peptides · 9 Mar 2026 · 12 likes I had written a reply contradicting post #19 and deleted it. Here is what survived. The distinction between "no evidence it works" and "evidence it does not work": we…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #140 · Sourcing › Independent verification · 27 Feb 2026 · 8 likes What I would tell a new member reading about interpreting a result for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Second pass at: Identical chromatograms across two different lots Replied, post #27 · Sourcing › Red flags · 25 Feb 2026 · 32 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #67 · Outcomes › Progress reports · 16 Feb 2026 · 0 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency. The general…
-
Coming back to: Light exposure: how much protection is proportionate? Started this topic · Practice › Storage & stability · 15 Feb 2026 · 0 likes Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Reading back through what has been written here about…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #75 · Clinical › Bloodwork · 13 Feb 2026 · 13 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters. The rule of thumb is fine; the edge…
-
Citation sweep results: how many references did not say what was claimed Replied, post #39 · Meta › Wiki maintenance · 1 Feb 2026 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. That matches how I use it. The general statement is what you check afterwards, not what you…
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #7 · Compounds › Secretagogues & GH axis · 28 Jan 2026 · 6 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #39 · Practice › Side effects · 26 Jan 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Blinding yourself: practical methods and their limits Replied, post #2 · Research Methods › N-of-1 designs · 25 Jan 2026 · 17 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #17 · Practice › Administration · 21 Jan 2026 · 5 likes Post #16 is right about the mechanism and I think understates the practical bit. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #86 · Practice › Side effects · 12 Jan 2026 · 27 likes Post #83 is right about the mechanism and I think understates the practical bit. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation…
-
Request: export my own posts — one year on Replied, post #31 · Meta › Feature requests · 7 Jan 2026 · 3 likes Taking post #30 at face value and following it one step further. Counter-request, gently: please do not add anything on hover. It does not exist on a phone and half the…
-
Coverage in the US: a map of the usual obstacles Replied, post #29 · Regional › North America · 30 Dec 2025 · 1 like Reframing coverage slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #50 · Analytics › Method validation · 26 Dec 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #20 · Compounds › Retatrutide · 17 Dec 2025 · 0 likes Building on post #19 rather than restating it. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the…
-
Tracking that stops updating and then resumes — the long version Replied, post #52 · Sourcing › Logistics · 16 Dec 2025 · 4 likes Carrier handover between an international and a domestic service is where tracking most often goes quiet, and it is usually silence rather than a problem. Adding it…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #20 · Data & Tools › Calculators · 27 Nov 2025 · 0 likes A definition problem is doing most of the work in this Feature request discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #138 · Start Here › How to Ask · 24 Nov 2025 · 33 likes Confirming post #136 from a second method, which matters more than confirming it from a second person. Five questions in one post gets you one answer: the easiest one,…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #29 · Compounds › Other compounds · 20 Nov 2025 · 12 likes The failure mode on AOD-9604 is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #82 · Analytics › HPLC & UHPLC · 14 Nov 2025 · 9 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Reading an interaction checker output critically Replied, post #37 · Practice › Interactions · 6 Nov 2025 · 0 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D,…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #2 · Compounds › Oral incretins · 25 Oct 2025 · 4 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #10 · Compounds › Retatrutide · 17 Oct 2025 · 0 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Dose-response in the phase 2 obesity work was clear across the studied range, with no…
-
Compounds this community declines to help with, and why Replied, post #50 · Compounds › Other compounds · 2 Oct 2025 · 0 likes Narrowing post #49, because the general version has more than one answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Pooling trials with different estimands — what changed since Replied, post #30 · Evidence › Meta-analyses · 28 Sep 2025 · 9 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. When trials differ in population, duration and comparator, the pooled estimate…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #5 · Analytics › HPLC & UHPLC · 19 Sep 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Titles that describe the question, not the situation — what changed since Replied, post #8 · Start Here › How to Ask · 11 Sep 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Do not apologise in the first line. It costs you the space where the question should be, and…
-
Meeting a protein target on a suppressed appetite Replied, post #18 · Nutrition & Training › Protein & intake · 28 Aug 2025 · 3 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #34 · Practice › Storage & stability · 25 Aug 2025 · 0 likes Agreed on power cut for eleven hours, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #100 · Compounds › Retatrutide · 24 Aug 2025 · 0 likes Post #97 answers the question as asked. The question underneath it is different. The reason Triple agonism keeps being re-asked is that the answer is conditional and…
-
Hypertension improvement and when medication needs revisiting Replied, post #17 · Clinical › Comorbidities · 20 Aug 2025 · 16 likes The honest answer on hypertension improvement is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #84 · Compounds › Repair & healing peptides · 15 Aug 2025 · 9 likes Post #80 describes the usual case. This is about the unusual one. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
How to research a compound with no human data without deceiving yourself Replied, post #106 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
-
Reading U-100 graduations, with a conversion table — what changed since Started this topic · Devices › Syringes & needles · 25 Jul 2025 · 1 like Reading U-100 graduations, with a conversion table — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2025 · 0 likes Post #2 answers the question as asked. The question underneath it is different. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere…
-
Repeatability versus intermediate precision Replied, post #122 · Analytics › Method validation · 2 Jul 2025 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #52 · Compounds › Repair & healing peptides · 28 Jun 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #143 · Evidence › Journal club · 22 Jun 2025 · 22 likes On SURMOUNT-1 I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Half-life, steady state, and accumulation worked through Replied, post #123 · Pharmacology › Pharmacokinetics · 15 Jun 2025 · 1 like Building on post #122 rather than restating it. Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration,…
-
Individual participant data versus aggregate data Replied, post #35 · Evidence › Meta-analyses · 10 Jun 2025 · 14 likes I read post #32 twice before replying, because I had assumed the opposite. The number people quote for individual participant data versus aggregate is a central…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #14 · Sourcing › Regulatory · 30 May 2025 · 1 like Whatever the answer on compound being unapproved turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #119 · Compounds › Semaglutide · 15 May 2025 · 3 likes I disagree with the framing of SELECT above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
Water content on a certificate and why it changes the arithmetic Replied, post #20 · Analytics › COA interpretation · 13 May 2025 · 3 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Which panel is worth repeating and which is worth ignoring Replied, post #17 · Clinical › Bloodwork · 11 May 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
A claim built entirely on a subgroup analysis Replied, post #27 · Evidence › Study critique · 10 May 2025 · 0 likes Worth separating two things that post #25 runs together. Small correction to my own earlier position on claim built. I had the units the wrong way round, which changes…
-
Dizziness on standing: the ordinary explanation first Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 24 Apr 2025 · 0 likes If someone has run dizziness on standing properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #22 · Compounds › Oral incretins · 24 Apr 2025 · 33 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #55 · Clinical › Comorbidities · 11 Apr 2025 · 0 likes A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history. Reporting the…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #139 · Access › International · 1 Apr 2025 · 0 likes On Cross-border purchase within the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #51 · Analytics › Mass spectrometry · 31 Mar 2025 · 22 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
-
Maintainer handover: how it works Replied, post #42 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes Everything in post #40 holds. The case it does not cover is the one I have. Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #11 · Access › Insurance & coverage · 11 Mar 2025 · 25 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
A page that has drifted out of date and needs a maintainer Replied, post #74 · Documentation › Wiki requests · 10 Mar 2025 · 1 like Confirming post #73 from a second method, which matters more than confirming it from a second person. Name a willing maintainer in the request. Point three of the…
-
When "no data" is the complete and final answer Replied, post #109 · Compounds › Other compounds · 5 Mar 2025 · 1 like Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #121 · Sourcing › Regulatory · 4 Mar 2025 · 17 likes I have three months of notes on pharmaceutical compounding rules and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew…
-
Follow-up: Requesting a page: what makes a good request Replied, post #3 · Documentation › Wiki requests · 18 Feb 2025 · 2 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Flag a page that has drifted: if you notice a maintained page has…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 31 Jan 2025 · 1 like This is the first time the answer has come with its own limits attached. Appreciated.
-
A supplier that answers analytical questions with restated claims Replied, post #12 · Sourcing › Red flags · 19 Jan 2025 · 32 likes Confirming post #11 from a second method, which matters more than confirming it from a second person. The strongest single signal available cheaply is what happens when…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #26 · Evidence › Journal club · 13 Jan 2025 · 19 likes An update on my earlier SUSTAIN 6 post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Revisiting: Moderation log format change Replied, post #56 · Meta › Announcements · 6 Dec 2024 · 24 likes I read post #52 twice before replying, because I had assumed the opposite. I would keep Moderation log format change and the decision it usually gets used for separate…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #36 · Clinical › Special populations · 22 Nov 2024 · 17 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
-
EMA product information as a primary source — does this still hold? Replied, post #33 · Regional › European Union · 15 Nov 2024 · 32 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. France: ANSM implements EU framework. Reimbursement has been narrower for weight…
-
Transporting a vial for a weekend away Replied, post #9 · Practice › Storage & stability · 26 Oct 2024 · 9 likes Adding the boring version of transporting a vial, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Progressive overload when the scale is falling — one year on Replied, post #111 · Nutrition & Training › Resistance training · 1 Oct 2024 · 3 likes I had written a reply contradicting post #109 and deleted it. Here is what survived. Trying to state the Progressive overload position in a way that someone who…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #23 · Clinical › Bloodwork · 11 Sep 2024 · 5 likes Thank you — that answers what I came here to find out.
-
Reporting a discrepancy without making an allegation Replied, post #64 · Sourcing › Vendor reports · 8 Sep 2024 · 19 likes Coming back to post #62, because the follow-up matters more than the original answer. Photograph the vial and the label before opening. It costs ten seconds and it is…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #15 · Clinical › Special populations · 4 Sep 2024 · 12 likes Where a labelling document addresses a population explicitly, that text is the single most useful thing to quote in a thread. It is a small point and it changes the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #88 · Research Methods › Statistics · 23 Aug 2024 · 18 likes Post #85 answers the question as asked. The question underneath it is different. Practical note on correlation: write down what you expect before you look. The number…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #29 · Analytics › COA interpretation · 10 Aug 2024 · 1 like What would change my mind on Purity assay versus content assay is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
-
The mass-error checker and its intended scope Replied, post #140 · Data & Tools › Calculators · 20 Jul 2024 · 12 likes Picking up post #139: that is the part I would want checked first. Mass-error checker is well covered in the tag pages, and the older discussions are better than the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #79 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.…